REGENXBIO, Inc. (RGNX)
9.27
+0.23
(+2.54%)
USD |
NASDAQ |
Mar 02, 16:00
9.42
+0.15
(+1.62%)
After-Hours: 20:00
REGENXBIO Accounts Payable (Quarterly) : 22.27M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 280.84M |
| BioMarin Pharmaceutical, Inc. | 312.77M |
| Omeros Corp. | 12.50M |
| Ultragenyx Pharmaceutical, Inc. | 31.00M |
| CytomX Therapeutics, Inc. | 0.646M |